Alexey Valeryevich Danilov

机构：City Of Hope National Medical Center, City of Hope · ORCID：0000-0003-4461-0970

发表论文 634 篇 · 总被引 7561 次 · h-index 42

代表论文

• Benefit of rituximab maintenance after first-line bendamustine-rituximab in patients with mantle cell lymphoma (2025 · Blood Advances · 被引 8)
• Bexobrutideg (NX-5948), a novel Bruton's tyrosine kinase (BTK) degrader, demonstrates rapid and durable clinical responses in Relapsed/Refractory chronic lymphocytic leukemia (CLL): New and updated findings from an ongoing Phase 1a/b trial (2025 · Blood · 被引 6)
• Interim analysis of the phase II study of glofitamab, lenaliomide and venetoclax (GLOVe) in untreated patients w/ high-risk mantle cell lymphoma. response and safety outcomes after the completion of stage 1 of 2 enrollment. (2025 · Blood · 被引 6)
• Clinical strategies for lymphoma management: Recommendations from the Bridging the Gaps in Leukemia, Lymphoma, and Multiple Myeloma Consensus Conference 2025 (2026 · Cancer · 被引 1)
• Humoral and functional SARS ‐ CoV ‐2‐specific T‐cell responses elicited in chronic lymphocytic leukaemia patients with GEO ‐ CM04S1 a synthetic MVA ‐vectored COVID ‐19 vaccine (2025 · British Journal of Haematology · 被引 1)
• Superior real-world outcomes of lisocabtagene maraleucel in chronic lymphocytic leukemia (2025 · Blood · 被引 1)